What question did this study set out to answer?

This research investigates how miR-221 and miR-222 influence proliferation and IL-6 release in airway smooth muscle from severe asthmatics.

March 14, 2026European Respiratory Journal

miR-221 and miR-222 target p21 and p27 in airway smooth muscle to elicit hyper proliferation in severe asthmatics

View Full Paper

Ask AI

Bookmark

Authors

MPMark M. PerryGreat Ormond Street Hospital JBJosie BakerThe Ohio State University KCKian Fan ChungImperial College London

Discussion

Member takes

Implication

Analysis shows miR-221 and miR-222 increase IL-6 release and proliferation in airway smooth muscle, indicating potential targets for therapy in severe asthma.

Key Points

This research investigates how miR-221 and miR-222 influence proliferation and IL-6 release in airway smooth muscle from severe asthmatics.
Human airway smooth muscle cells were exposed to FCS and TGF-β for 8 days.
IL-6 levels in supernatants were quantified using DuoSet ELISA.
Cell proliferation was measured using a BrdU assay.
miRNA and mRNA expression analyses were performed via TaqMan RT-PCR.
Transfections were conducted to assess the functions of miR-221 and miR-222 using mimics and inhibitors.
FCS and TGF-β stimulation increased cell proliferation and IL-6 release.
miR-221 and miR-222 expression levels rose in response to FCS and TGF-β.
Patients with severe asthma exhibited greater increases compared to those with non-severe asthma.
Transfection with miRNA-222 inhibitors reduced proliferation and IL-6 release, while mimics enhanced these effects by targeting p21 and p27.

Cite This Study

Perry et al. (2011) studied this question.

synapsesocial.com/papers/69b4fc1fb39f7826a300cd2f https://doi.org/10.1183/13993003/erj.38.suppl_55.p749

View Full Paper

Ask AI

Bookmark

March 14, 2026European Respiratory Journal

miR-221 and miR-222 target p21 and p27 in airway smooth muscle to elicit hyper proliferation in severe asthmatics

View Full Paper

Ask AI

Bookmark

Authors

MPMark M. PerryGreat Ormond Street Hospital JBJosie BakerThe Ohio State University KCKian Fan ChungImperial College London

Discussion

Member takes

Implication

Analysis shows miR-221 and miR-222 increase IL-6 release and proliferation in airway smooth muscle, indicating potential targets for therapy in severe asthma.

Key Points

This research investigates how miR-221 and miR-222 influence proliferation and IL-6 release in airway smooth muscle from severe asthmatics.
Human airway smooth muscle cells were exposed to FCS and TGF-β for 8 days.
IL-6 levels in supernatants were quantified using DuoSet ELISA.
Cell proliferation was measured using a BrdU assay.
miRNA and mRNA expression analyses were performed via TaqMan RT-PCR.
Transfections were conducted to assess the functions of miR-221 and miR-222 using mimics and inhibitors.
FCS and TGF-β stimulation increased cell proliferation and IL-6 release.
miR-221 and miR-222 expression levels rose in response to FCS and TGF-β.
Patients with severe asthma exhibited greater increases compared to those with non-severe asthma.
Transfection with miRNA-222 inhibitors reduced proliferation and IL-6 release, while mimics enhanced these effects by targeting p21 and p27.

Cite This Study

Perry et al. (2011) studied this question.

synapsesocial.com/papers/69b4fc1fb39f7826a300cd2f https://doi.org/10.1183/13993003/erj.38.suppl_55.p749

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark